ABVC BioPharma, Inc. Other Receivable After Allowance For Credit Loss Noncurrent
ABVC BioPharma, Inc. (ABVC) had Other Receivable After Allowance For Credit Loss Noncurrent of TWD 3.94 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › and Others › Nontrade Receivables › Other Receivable, after Allowance for Credit Loss, Noncurrent
us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent · last filed 2025-08-13
- 2024-03-31: Other Receivable After Allowance For Credit Loss Noncurrent $123.36K.
- 2023-12-31: Other Receivable After Allowance For Credit Loss Noncurrent $113.52K.
- 2022-12-31: Other Receivable After Allowance For Credit Loss Noncurrent $865.48K.
USD
| Period end | Other Receivable After Allowance For Credit Loss Noncurrent |
|---|---|
| 2024-03-31 | $123.36K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $113.52K 10-Q · filed 2024-05-17 |
| 2022-12-31 | $865.48K 10-K · filed 2024-03-13 |
TWD
| Period end | Other Receivable After Allowance For Credit Loss Noncurrent |
|---|---|
| 2025-06-30 | 3.94M TWD 10-Q · filed 2025-08-13 |
| 2025-03-31 | 3.94M TWD 10-Q · filed 2025-04-30 |
| 2024-12-31 | 3.94M TWD 10-K · filed 2025-04-15 |